HAYWARD, Calif., May 8 /PRNewswire-FirstCall/ -- Thermage, Inc. , a leader in non-invasive tissue tightening in the aesthetic industry, today announced the nomination of Cathy McCarthy, 59, President and Chief Operating Officer of SM&A, and Marti Morfitt, 49, former President and Chief Executive Officer of CNS, Inc., for election to its Board of Directors at the 2007 Annual Stockholders’ Meeting. Assuming their election, the Company would expect Ms. McCarthy to serve on the Audit and Compensation Committees and Ms. Morfitt to serve on the Nominating and Corporate Governance Committee. Ms. McCarthy and Ms. Morfitt will fill vacancies left by Bob Byrnes and Sam Colella, respectively.
“We are delighted that Cathy and Marti have agreed to be nominated to join our Board of Directors,” said Stephen J. Fanning, Chairman, President and Chief Executive Officer of Thermage. “Both are well respected in the investment community and will add a tremendous amount of depth through their experiences at two rapidly growing publicly-traded companies. Cathy brings 35 years of financial and management experience and is a strong addition to our Audit and Compensation committees, and Marti brings 20 years of executive leadership experience to our Nominating and Corporate Governance Committee. Their expertise will be invaluable as we continue to grow our product portfolio, expand our presence worldwide, and increase awareness of the Thermage brand. I would also like to express my thanks and appreciation to Bob Byrnes and Sam Colella for their long-standing support of the Company.”
Ms. McCarthy is the President and COO of SM&A, a leading provider of business capture and program support services. Throughout her career, she has worked in the consulting, consumer and banking industries. As a former CFO for four young companies, Ms. McCarthy has hands-on experience with current financial issues facing growing public firms, including Sarbanes-Oxley compliance and corporate governance as well as mergers and acquisitions. Ms. McCarthy joined SM&A in 2000 as its CFO. She previously held senior finance positions with PIA Merchandising, Giant Group and Wherehouse Entertainment, and served as a vice president at Mellon Bank, N.A. until 1989.
“I am pleased to be nominated to join the Thermage Board,” said Ms. McCarthy. “This is an exciting time as the Company continues its momentum to increase its range of product tips and applications, expand into new markets and demonstrate strong revenue growth and improved profitability. I look forward to working with the Board and management team to support the Company in its vision and growth.”
Ms. Morfitt brings 24 years of senior management experience with consumer goods companies, most recently as the President and CEO of CNS, Inc., until it was acquired by GlaxoSmithKline in December 2006. Prior to joining CNS in 1998, Ms. Morfitt served in a variety of senior management and marketing positions with The Pillsbury Company, including leadership in its Meals division, Green Giant Brands group, and Fraser Valley Foods Company, where she was responsible for strategic direction, operations, financial results and brand building. She has served on six corporate and not-for-profit Boards of Directors and is currently on the Board of Graco Inc., an industrial goods company.
“I am honored with this nomination to the Thermage Board of Directors,” said Ms. Morfitt. “The Company has positioned itself for continued growth through its focus on patients and physician customers, broad product offering, strong marketing efforts and solid operations. They are doing an excellent job in generating brand awareness in the growing aesthetics industry. I look forward to contributing to the Company’s future success.”
About Thermage, Inc.
Thermage’s innovative technology provides a unique non-invasive procedure designed to tighten and contour skin, significantly expanding the non-invasive aesthetic applications physicians can offer to the rapidly growing “anti- aging” market. For more information, call 1-510-259-7117 or visit http://www.thermage.com.
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning Thermage’s ability to improve its financial performance, expand into new markets, successfully introduce new and improved procedures and treatment tips, and its ability to successfully generate awareness, demand and build the Thermage brand, are forward-looking statements within the meaning of the Safe Harbor. Forward-looking statements are based on management’s current, preliminary expectations and are subject to risks and uncertainties, which may cause Thermage’s actual results to differ materially from the statements contained herein. Further information on potential risk factors that could affect Thermage’s business and its financial results are detailed in its Form 10-K/A as filed with the Securities and Exchange Commission on April 30, 2007. Undue reliance should not be placed on forward- looking statements, which speaks only as of the date they are made. Thermage undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.
Thermage, Inc.
CONTACT: Investors, Douglas Sherk or Jenifer Kirtland, +1-415-896-6820, orMedia, Steve DiMattia or Jennifer Saunders, +1-646-201-5445, all of EVCGroup, Inc., for Thermage, Inc.
Web site: http://www.thermage.com//
